Report Detail

Request for Sample of this report

Chemical & Material Global Palonosetron HCl API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4646012
    • |
  • 09 November, 2025
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Palonosetron HCl API market size was valued at US$ 397 million in 2024 and is forecast to a readjusted size of USD 521 million by 2031 with a CAGR of 4.0% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Palonosetron HCl API (Active Pharmaceutical Ingredient) is a key substance used in the formulation of medications designed to combat chemotherapy-induced nausea and vomiting (CINV) as well as postoperative nausea and vomiting (PONV). It is a potent and highly selective 5-HT3 receptor antagonist. Chemically synthesized through specific processes, Palonosetron HCl API works by binding to and blocking the 5-HT3 receptors, thereby preventing the activation of the emetic reflex pathway that is triggered by serotonin release. Incorporated into finished pharmaceutical products in precise dosages, it plays a vital role in providing relief to patients experiencing nausea and vomiting associated with certain medical treatments and procedures.
This report is a detailed and comprehensive analysis for global Palonosetron HCl API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Palonosetron HCl API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Palonosetron HCl API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Palonosetron HCl API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Palonosetron HCl API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Palonosetron HCl API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Palonosetron HCl API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Century Pharmaceuticals, Dr Reddys Laboratories Ltd, Seqens, Tyche Industries Ltd, Teva Pharmaceutical Industries Ltd, Usv Private Ltd, Cipla Ltd, Qilu Pharmaceutical Co Ltd, Alp Pharm Beijing Co Ltd, Qingdao Fengchen Technology and Trade Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Palonosetron HCl API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
1kg Package
5kg Package
Others
Market segment by Application
Tablet Product
Capsule Product
Others
Major players covered
Century Pharmaceuticals
Dr Reddys Laboratories Ltd
Seqens
Tyche Industries Ltd
Teva Pharmaceutical Industries Ltd
Usv Private Ltd
Cipla Ltd
Qilu Pharmaceutical Co Ltd
Alp Pharm Beijing Co Ltd
Qingdao Fengchen Technology and Trade Co., Ltd.
LGC Limited
Assia Chemical Industries Ltd
Shandong Keyuan Pharmaceutical
Midas Pharma
Anant Pharmaceuticals Pvt. Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Palonosetron HCl API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Palonosetron HCl API, with price, sales quantity, revenue, and global market share of Palonosetron HCl API from 2020 to 2025.
Chapter 3, the Palonosetron HCl API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Palonosetron HCl API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Palonosetron HCl API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Palonosetron HCl API.
Chapter 14 and 15, to describe Palonosetron HCl API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Palonosetron HCl API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 1kg Package
    • 1.3.3 5kg Package
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Palonosetron HCl API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Tablet Product
    • 1.4.3 Capsule Product
    • 1.4.4 Others
  • 1.5 Global Palonosetron HCl API Market Size & Forecast
    • 1.5.1 Global Palonosetron HCl API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Palonosetron HCl API Sales Quantity (2020-2031)
    • 1.5.3 Global Palonosetron HCl API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Century Pharmaceuticals
    • 2.1.1 Century Pharmaceuticals Details
    • 2.1.2 Century Pharmaceuticals Major Business
    • 2.1.3 Century Pharmaceuticals Palonosetron HCl API Product and Services
    • 2.1.4 Century Pharmaceuticals Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Century Pharmaceuticals Recent Developments/Updates
  • 2.2 Dr Reddys Laboratories Ltd
    • 2.2.1 Dr Reddys Laboratories Ltd Details
    • 2.2.2 Dr Reddys Laboratories Ltd Major Business
    • 2.2.3 Dr Reddys Laboratories Ltd Palonosetron HCl API Product and Services
    • 2.2.4 Dr Reddys Laboratories Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
  • 2.3 Seqens
    • 2.3.1 Seqens Details
    • 2.3.2 Seqens Major Business
    • 2.3.3 Seqens Palonosetron HCl API Product and Services
    • 2.3.4 Seqens Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Seqens Recent Developments/Updates
  • 2.4 Tyche Industries Ltd
    • 2.4.1 Tyche Industries Ltd Details
    • 2.4.2 Tyche Industries Ltd Major Business
    • 2.4.3 Tyche Industries Ltd Palonosetron HCl API Product and Services
    • 2.4.4 Tyche Industries Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Tyche Industries Ltd Recent Developments/Updates
  • 2.5 Teva Pharmaceutical Industries Ltd
    • 2.5.1 Teva Pharmaceutical Industries Ltd Details
    • 2.5.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.5.3 Teva Pharmaceutical Industries Ltd Palonosetron HCl API Product and Services
    • 2.5.4 Teva Pharmaceutical Industries Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.6 Usv Private Ltd
    • 2.6.1 Usv Private Ltd Details
    • 2.6.2 Usv Private Ltd Major Business
    • 2.6.3 Usv Private Ltd Palonosetron HCl API Product and Services
    • 2.6.4 Usv Private Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Usv Private Ltd Recent Developments/Updates
  • 2.7 Cipla Ltd
    • 2.7.1 Cipla Ltd Details
    • 2.7.2 Cipla Ltd Major Business
    • 2.7.3 Cipla Ltd Palonosetron HCl API Product and Services
    • 2.7.4 Cipla Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cipla Ltd Recent Developments/Updates
  • 2.8 Qilu Pharmaceutical Co Ltd
    • 2.8.1 Qilu Pharmaceutical Co Ltd Details
    • 2.8.2 Qilu Pharmaceutical Co Ltd Major Business
    • 2.8.3 Qilu Pharmaceutical Co Ltd Palonosetron HCl API Product and Services
    • 2.8.4 Qilu Pharmaceutical Co Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Qilu Pharmaceutical Co Ltd Recent Developments/Updates
  • 2.9 Alp Pharm Beijing Co Ltd
    • 2.9.1 Alp Pharm Beijing Co Ltd Details
    • 2.9.2 Alp Pharm Beijing Co Ltd Major Business
    • 2.9.3 Alp Pharm Beijing Co Ltd Palonosetron HCl API Product and Services
    • 2.9.4 Alp Pharm Beijing Co Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Alp Pharm Beijing Co Ltd Recent Developments/Updates
  • 2.10 Qingdao Fengchen Technology and Trade Co., Ltd.
    • 2.10.1 Qingdao Fengchen Technology and Trade Co., Ltd. Details
    • 2.10.2 Qingdao Fengchen Technology and Trade Co., Ltd. Major Business
    • 2.10.3 Qingdao Fengchen Technology and Trade Co., Ltd. Palonosetron HCl API Product and Services
    • 2.10.4 Qingdao Fengchen Technology and Trade Co., Ltd. Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Qingdao Fengchen Technology and Trade Co., Ltd. Recent Developments/Updates
  • 2.11 LGC Limited
    • 2.11.1 LGC Limited Details
    • 2.11.2 LGC Limited Major Business
    • 2.11.3 LGC Limited Palonosetron HCl API Product and Services
    • 2.11.4 LGC Limited Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 LGC Limited Recent Developments/Updates
  • 2.12 Assia Chemical Industries Ltd
    • 2.12.1 Assia Chemical Industries Ltd Details
    • 2.12.2 Assia Chemical Industries Ltd Major Business
    • 2.12.3 Assia Chemical Industries Ltd Palonosetron HCl API Product and Services
    • 2.12.4 Assia Chemical Industries Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Assia Chemical Industries Ltd Recent Developments/Updates
  • 2.13 Shandong Keyuan Pharmaceutical
    • 2.13.1 Shandong Keyuan Pharmaceutical Details
    • 2.13.2 Shandong Keyuan Pharmaceutical Major Business
    • 2.13.3 Shandong Keyuan Pharmaceutical Palonosetron HCl API Product and Services
    • 2.13.4 Shandong Keyuan Pharmaceutical Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Shandong Keyuan Pharmaceutical Recent Developments/Updates
  • 2.14 Midas Pharma
    • 2.14.1 Midas Pharma Details
    • 2.14.2 Midas Pharma Major Business
    • 2.14.3 Midas Pharma Palonosetron HCl API Product and Services
    • 2.14.4 Midas Pharma Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Midas Pharma Recent Developments/Updates
  • 2.15 Anant Pharmaceuticals Pvt. Ltd
    • 2.15.1 Anant Pharmaceuticals Pvt. Ltd Details
    • 2.15.2 Anant Pharmaceuticals Pvt. Ltd Major Business
    • 2.15.3 Anant Pharmaceuticals Pvt. Ltd Palonosetron HCl API Product and Services
    • 2.15.4 Anant Pharmaceuticals Pvt. Ltd Palonosetron HCl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Anant Pharmaceuticals Pvt. Ltd Recent Developments/Updates

3 Competitive Environment: Palonosetron HCl API by Manufacturer

  • 3.1 Global Palonosetron HCl API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Palonosetron HCl API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Palonosetron HCl API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Palonosetron HCl API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Palonosetron HCl API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Palonosetron HCl API Manufacturer Market Share in 2024
  • 3.5 Palonosetron HCl API Market: Overall Company Footprint Analysis
    • 3.5.1 Palonosetron HCl API Market: Region Footprint
    • 3.5.2 Palonosetron HCl API Market: Company Product Type Footprint
    • 3.5.3 Palonosetron HCl API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Palonosetron HCl API Market Size by Region
    • 4.1.1 Global Palonosetron HCl API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Palonosetron HCl API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Palonosetron HCl API Average Price by Region (2020-2031)
  • 4.2 North America Palonosetron HCl API Consumption Value (2020-2031)
  • 4.3 Europe Palonosetron HCl API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Palonosetron HCl API Consumption Value (2020-2031)
  • 4.5 South America Palonosetron HCl API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Palonosetron HCl API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 5.2 Global Palonosetron HCl API Consumption Value by Type (2020-2031)
  • 5.3 Global Palonosetron HCl API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 6.2 Global Palonosetron HCl API Consumption Value by Application (2020-2031)
  • 6.3 Global Palonosetron HCl API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 7.2 North America Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 7.3 North America Palonosetron HCl API Market Size by Country
    • 7.3.1 North America Palonosetron HCl API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Palonosetron HCl API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Palonosetron HCl API Market Size by Country
    • 8.3.1 Europe Palonosetron HCl API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Palonosetron HCl API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Palonosetron HCl API Market Size by Region
    • 9.3.1 Asia-Pacific Palonosetron HCl API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Palonosetron HCl API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 10.2 South America Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 10.3 South America Palonosetron HCl API Market Size by Country
    • 10.3.1 South America Palonosetron HCl API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Palonosetron HCl API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Palonosetron HCl API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Palonosetron HCl API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Palonosetron HCl API Market Size by Country
    • 11.3.1 Middle East & Africa Palonosetron HCl API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Palonosetron HCl API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Palonosetron HCl API Market Drivers
  • 12.2 Palonosetron HCl API Market Restraints
  • 12.3 Palonosetron HCl API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Palonosetron HCl API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Palonosetron HCl API
  • 13.3 Palonosetron HCl API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Palonosetron HCl API Typical Distributors
  • 14.3 Palonosetron HCl API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Palonosetron HCl API. Industry analysis & Market Report on Palonosetron HCl API is a syndicated market report, published as Global Palonosetron HCl API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Palonosetron HCl API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo